Biologics and Biosimilars: What Patients, Physicians and Advocates Need to Know Access, Patient Safety and Emerging Policy Issues
September 28, 2011
The Alliance for Safe Biologic Medicines joined with the Virginia Biotechnology Association at an event to expore with patients, advocates, physicians and other healthcare providers the importance of maintaining patient safety as the U.S. FDA’s top priority while it works to establish a pathway for approval for biosimilar products. Continue reading…